Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
Cingulate Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).
- Exchange
- nasdaq
- Notice
- extension granted
- Deficiency
- stockholders equity
- Rules
- 5550(b)(1)
Exact text from the filing
February 22, 2024, the Nasdaq Hearings Panel (the “Panel”) notified Cingulate Inc. (the “Company”) that (i) as a result of the appointment of three independent board members on February 12, 2024, it had regained compliance with the board composition requirements of Nasdaq set forth in Nasdaq Listing Rule 5605 and (ii) it has granted the Company’s request for an exception to evidence continued compliance with the minimum stockholders’ equity requirement of $2.5 million under the Nasdaq Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Rule”) for continued listing through May 13, 2024 (
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Cingulate Inc. received a nasdaq noncompliance notice notice regarding board independence (rules 5605).
- Exchange
- nasdaq
- Notice
- noncompliance notice
- Deficiency
- board independence
- Rules
- 5605
Exact text from the filing
December 26, 2023, the Company received an additional letter from the Staff indicating that, based upon the resignation of three members of the Company’s board of directors on December 12, 2023 and December 13, 2023, the Company no longer complied with the independent director, audit committee, compensation committee and independent director oversight of director nominations requirements as set forth in Nasdaq Listing Rule 5605. Pursuant to the Exception, the Company is required to provide the Panel with prompt notification of any significant events that occur including any event that may call
View on SEC.gov